慢性辅助性中耳炎的流行病学:系统性审查以估计全球患病率
Anjola Onifade1, Henriette Wa Katolo2, Siddharth Mookerjee3,4
1Department of ENT, University Hospitals Sussex, Brighton and Hove, UK. anjola.onifade@nhs.net.
Journal of epidemiology and global health
|April 3, 2025
概括
慢性辅助性中耳炎 (CSOM) 影响全球2.97亿人,其中85%在低收入和中等收入国家. 这种耳部疾病导致严重的听力损失,并强调需要紧急的公共卫生干预措施.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 慢性支性中耳炎 (CSOM) 是一种普遍存在的耳部疾病,其特征是耳膜穿孔,导致排泄和听力损失.
- 在教育和就业方面,CSOM显著影响生活质量,造成社会耻辱和边缘化.
- 之前的CSOM全球流行率估计约为2亿,但存在潜在的方法限制.
研究的目的:
- 系统地审查和估计慢性辅助性中耳炎 (CSOM) 目前的全球患病率.
- 为了确定相关的风险因素和CSOM患者听力损失的负担.
- 为公共卫生政策和干预计划提供最新的流行病学数据.
主要方法:
- 按照PRISMA指南进行了系统的文献审查,搜索了Ovid和Embase数据库.
- 包括2004年至2025年3月出版的原始基于社区的CSOM研究,不包括基于医院的研究.
- 从29个符合条件的横截面研究中提取和分析了有关患病率和风险因素的数据.
主要成果:
- 据估计,CSOM的全球总流行率为全球人口的3.8%,相当于2.97亿人.
- 在低收入和中等收入国家 (LMICs) 观察到不成比例的负担,占病例的85% (25200万).
- 在受影响者中,6400万患有双边疾病,184万患有残疾性听力损失 (>25-30dB).
结论:
- 在全球范围内,CSOM对全球健康造成了巨大的负担,对LMICs产生了重大影响.
- 调查结果强调,迫切需要针对CSOM制定有针对性的预防和管理战略.
- 医疗保健提供者和政策制定者应该优先考虑解决这种耳部疾病广泛影响的举措.
相关概念视频
Chronic Pharyngitis
738
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
738
Tonsillitis I: Introduction
190
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Etiology
Three primary contributing factors have been identified.
190
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Tonsillitis II: Management
98
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
98
Healthcare Associated Infections II: Preventive Measures
2.3K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.3K


